James Kopp
Gastroenterology · Anderson, SCNPI 1477503894
Payments from drug & device makers
Across 555 payments — averaging $4152.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$717K
- Janssen Research & Development, LLC$355K
- Emergent Biosolutions Inc.$308K
- AbbVie$261K
- Modernatx, Inc.$197K
- Novartis$88K
- plus $378K from 14 others
What the payments were for
- Travel & lodging$1,48269%
- Food & beverage$65931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 45 | $716,726 |
| Janssen Research & Development, LLC | 30 | $355,285 |
| Emergent Biosolutions Inc. | 12 | $308,241 |
| AbbVie(2 entities) | 161 | $261,242 |
| Modernatx, Inc. | 143 | $196,949 |
| Novartis | 5 | $88,087 |
| Eli Lilly | 8 | $83,061 |
| Regeneron | 17 | $66,160 |
| Braintree Laboratories, Inc. | 8 | $48,952 |
| Pfizer | 8 | $43,500 |
| Novavax Inc | 10 | $35,555 |
| AstraZeneca | 4 | $25,904 |
| Ironwood Pharmaceuticals, Inc | 6 | $25,283 |
| Boehringer Ingelheim International GmbH | 71 | $24,091 |
| Astrazeneca UK Limited | 2 | $14,752 |
| Sanofi US Services Inc. | 3 | $4,664 |
| Kowa Research Institute, Inc. | 2 | $2,497 |
| Bavarian Nordic A/s | 3 | $2,300 |
| Boehringer Ingelheim | 3 | $1,267 |
| GSK | 14 | $176 |
How this compares
$2,304,694 in reported general payments places this provider in the 95th percentile of 259 gastroenterology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $11,751 |
| Oxycodone Hcl | 12 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $43,500 | $11,75113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 259 gastroenterology providers in South Carolina.
Other gastroenterology in Anderson
- Manjakkollai VeerabaguAnderson$24K
- Erin ForsterCharleston$2M
- Suzy KimGreenville$1.5M
- Narayanachar MuraliOrangeburg$1.4M
- Brett van Leer GreenbergSummerville$1.1M
- Edward KimbroughColumbia$1M
- Gary AbramsGreenville$925K
- Mark DeleggeCharleston$578K
- Matthew BarnesGreenville$565K
- Brenda HoffmanCharleston$433K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.